Showing results (21-30 of 1,607) with videos related to
Sort By:
Pageof 161
Journal of the American Society of Nephrology : JASN|July 1, 1995
Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patientsJ Bachmann, M Tepel, H Raidt, et al.Planta Medica|September 14, 2000
Bioavailability and pharmacokinetics of natural volatile terpenes in animals and humansC Kohlert, I van Rensen, R März, et al.International Journal of Clinical Pharmacology and Therapeutics|September 30, 2010
Evaluation of the pharmacokinetic interaction between the dipeptidyl peptidase-4 inhibitor linagliptin and pioglitazone in healthy volunteersE U Graefe-Mody, A Jungnik, A Ring, et al.European Journal of Drug Metabolism and Pharmacokinetics|February 23, 2011
Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteersC Friedrich, A Ring, T Brand, et al.Diabetes, Obesity & Metabolism|May 30, 2009
Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patientsT Heise, E U Graefe-Mody, S Hüttner, et al.Diabetes, Obesity & Metabolism|March 1, 2011
The oral DPP-4 inhibitor linagliptin significantly lowers HbA1c after 4 weeks of treatment in patients with type 2 diabetes mellitusT Forst, B Uhlig-Laske, A Ring, et al.Forensic Science International|September 27, 2005
Evaluation of the correlation between time corpses spent in in-ground graves and findings at exhumationD Breitmeier, U Graefe-Kirci, K Albrecht, et al.Nephron|November 27, 1999
Evidence of altered homocysteine metabolism in chronic renal failureB F Henning, R Riezler, M Tepel, et al.Journal of Thrombosis and Haemostasis : JTH|July 15, 2006
Pharmacokinetics and pharmacodynamics of BIBT 986, a novel small molecule dual inhibitor of thrombin and factor XaE U Graefe-Mody, U Schühly, K Rathgen, et al.International Journal of Clinical Pharmacology and Therapeutics|May 6, 2011
Effect of linagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteersE U Graefe-Mody, T Brand, A Ring, et al.Pageof 161